Accéder au contenu
Merck
  • In vivo production of interferon beta by human Tenon's fibroblasts; a possible mediator for the development of chronic conjunctival inflammation.

In vivo production of interferon beta by human Tenon's fibroblasts; a possible mediator for the development of chronic conjunctival inflammation.

The British journal of ophthalmology (2002-05-30)
L Chang, D Siriwardena, M R Wilkins, J G Crowston, A N Akbar, P T Khaw
RÉSUMÉ

Chronic inflammation may develop from failure of the immune system to deactivate itself during resolution of the wound healing response, and is recognised as a major risk factor for trabeculectomy failure. Fibroblast/T cell interactions may contribute to aggressive scarring. Our previous research showed that in vitro human Tenon's fibroblast produced interferon beta was responsible for preventing T cell apoptosis, suggesting that this interaction could contribute to the development of chronic inflammation. Immunohistological techniques were used to investigate the in vivo components of this particular fibroblast/T cell interaction in conjunctival biopsies from glaucoma patients undergoing filtration surgery. Fibroblast produced interferon beta and T lymphocytes were identified in human conjunctiva. The components of fibroblast mediated prevention of T cell apoptosis were identified in vivo, suggesting that the development of this interaction is possible and that it may contribute to the development of chronic inflammation and excessive scarring.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
IgG2a, Kappa from murine myeloma, clone UPC 10, purified immunoglobulin, buffered aqueous solution